Biotech China 2014

Biology: GlaxoSmithKline

Total Score People Score Events Score
16 14 14
Date Event Presentation Speakers
March 19, 2014 3rd Neurological Biomarkers A post-GWAS Method for Translating Statistical Associations to Disease-relevant Pathways Allen Roses
May 31, 2013 ASCO Annual Meeting 2013 Special Session Catherine Wang
April 6, 2013 AACR Annual Meetings From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA Dashyant Dhanak
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC Tona M Gilmer, Axel Hoos
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Plenary: Repurposing Compounds for CNS Targets: Utilizing Translational Bioinformatics Pankaj Agarwal
September 3, 2012 Ourense Conference on Imaging Mass Spectrometry Observing Directly the Distribution of an Inhaled Domain Antibody in Healthy and Infected Mice by MALDI MS Imaging Peter S. Marshall
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) Immunotherapy: Helping the Host | TLR4 Agonists Facilitate “Rapid Acting Vaccine” Against the Respiratory Tract Pathogen, Influenza A Jory R. Baldridge
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Immunity in Respiratory Tract (X6) | TLR4 Agonists Facilitate “Rapid Acting Vaccine” Against the Respiratory Tract Pathogen, Influenza A Jory R. Baldridge
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Cancer Vaccines: Prophylaxy or Therapy | Development of the MAGE-A3 ASCI: From Tumor Specificity to Predictive Biomarkers Vincent G Brichard
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis An Effective Framework for Omic Data Analysis Jie J. Cheng
January 26, 2009 7th Annual Partnering with Central Labs B1 : How to Reduce the Burden on Smaller Sponsor Clinical Team-The Cross Functional Approach Karen Turner
March 30, 2008 Nuclear Receptors: Steroid Sisters Drug Development Dennis Sprecher
March 30, 2008 Nuclear Receptors: Orphan Brothers Drug Development Dennis Sprecher
March 25, 2008 RNAi, MicroRNA, and Non-Coding RNA MicroRNAs and Their Targets (Plants and Invertebrates) Eric C Lai
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SELECTING LEADS AND DETECTING ADVERSE ACTIVITY (14:00-17:30) Dana E. Vanderwall
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Analysis of Biological Mechanism of Action, and Characterization of Profiles across the Progression Path (14:05-14:35) Dana E. Vanderwall
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.